MedPath

Plasma Neurofilament Light and Its Relationship With Omega-3 Status and Soccer Heading in Women Soccer Players

Completed
Conditions
Brain Trauma
Registration Number
NCT05457023
Lead Sponsor
University of Kansas Medical Center
Brief Summary

The purpose of this study is to (1) assess how a competitive season of purposeful gameplay soccer heading in collegiate women soccer players is related to a blood biomarker for sports-related brain injury, plasma neurofilament light (NF-L), and (2) examine how a player's omega-3 status is related to plasma NF-L concentration changes during and after a competitive season of gameplay soccer heading.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
27
Inclusion Criteria
  • At least 18 years of age.
  • Active player on the university's current team roster for the upcoming competitive season.
  • Is eligible to participate in games and is not redshirting.
Exclusion Criteria
  • Is recovering from a Physician diagnosed concussion.
  • Is recovering from another injury prohibiting the study participant from participating in all sport-related activities.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in plasma neurofilament light concentrations from baseline, during, and after a competitive season.Baseline, 1 Months, 2 Months, 3 Months, 6 Months

Plasma neurofilament light (pg/mL) is a biomarker of axonal brain injury following sports-related head impacts.

Change in purposeful soccer heading frequencies from baseline, during, and after a competitive season.Baseline, 2 weeks, 4 weeks, 6 weeks, 8 weeks, 10 weeks, 12 weeks, 14 weeks

HeadCount is a web-based, structured, self-administered questionnaire to assess longer-term heading frequencies (#) during competitive play and is administered bi-weekly.

Change in Omega-3 status from baseline, during, and after a competitive season.Baseline, 1 Months, 2 Months, 3 Months, 6 Months

Omega-3 Index (%) is the omega-3 fatty acid content of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) within membrane of red blood cell. It is expressed as EPA+DHA as a percent of total identified fatty acids.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

University of Missouri Kansas City

🇺🇸

Kansas City, Missouri, United States

Rockhurst University

🇺🇸

Kansas City, Missouri, United States

University of Missouri Kansas City
🇺🇸Kansas City, Missouri, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.